Available data indicate that there are gender differences in many features of Parkinson's disease (PD). Precise identification of the gender differences is important to tailor treatment, predict outcomes, and meet other individual and social needs in women and men with PD. The aim of this study was to review the available clinical data on gender differences in PD. Original articles and meta-analyses published between 1990 and 2016 systematically exploring gender differences in PD were reviewed. There is slight male preponderance in incidence and prevalence of PD. PD starts earlier in men. Women tend to be more prone to develop tremor-dominant PD but are less rigid than men.
| RESULTS AND DISCUSSION

| Gender differences in incidence, prevalence, age at onset, and risk factors in PD patients
In most of the studies reviewed here, the number of men with PD outweighed the number of women ( Table 1 ). The total number of women with PD in the reviewed articles was 12 994 (41%), and the total number of men with PD was 18 302 (59%). Indeed, one of the most commonly reported gender differences in PD is that women are less likely to get PD. For example, Baldereschi et al. 10 reported greater incidence of PD in men (41.1/100 000 annually) than in women (21.7/10 000 annually) including all age groups. This has been replicated in other studies. [11] [12] [13] In addition, the prevalence is also higher in men than in women with PD (around 30/10 000 and 24/10 000, respectively), [13] [14] [15] and according to some studies, men have up to twice as higher risk than women to develop PD. [16] [17] [18] Regarding the age at disease onset, even though some studies have found that PD starts earlier in men, 19, 20 others showed no difference between sexes in mean age at PD onset and age at PD diagnosis. 21 Similar findings were reported by Baba et al. 22 and Scott et al. 23 who also found no differences in age at disease onset and duration of symptoms before diagnosis, or disease duration from diagnosis between sexes. Risk factors for PD did also differ in men and women; for example, Savica et al. 24 found that in men risks included lack of coffee consumption, head trauma, and exposure to pesticides, while anemia was a risk factor in women. In a recent study, high urate levels in men but not in women were associated with lower future risk to develop PD. 25 Regarding gender differences in genetic risk factors to develop PD, the studies are not consistent: While some studies report a female preponderance in leucine-rich repeat kinase 2 (LRRK2)-positive PD, 26 other studies did not find any gender differences. 27 Interestingly, having a child with LRRK2 mutation seems to be related to higher risk of PD in the parents, as does having a daughter no matter the genetic status of the offspring. 28 Genetic influence might also have a genderspecific effect on environmental risk factors such as smoking; for example, monoamine oxidase B (MAO-B) genotype was shown to have a modifying effect on the inverse relationship between smoking and PD in men, but not in women. 29 In addition, there is also evidence that there might be gender-related differences in gene expression in human dopaminergic neurons in SNc (eg, upregulation of alpha-synuclein and PTEN-induced kinase 1 (PINK1) genes in men, but not in women 30 ), which might at least partially explain the gender differences in clinical presentation and response to treatment in PD. 31, 32 No gender differences in incidence/prevalence or other disease characteristics have been reported for parkin 33 or glucocerebrosidase genes. 34 In conclusion, there is evidence suggesting that men are at higher risk to develop PD. The reason behind this is not well understood.
Some data suggest that this might be related to the protective role of estrogens in women, 35, 36 as the incidence of PD becomes more even across sexes in post-menopausal women. 37 This is also supported by data showing lower level of sex hormones in men with PD compared to healthy controls. 38 In addition, evidence shows that women with PD experience early menopause and undergo hysterectomy more frequently compared to controls. 39 The gender difference in prevalence and incidence of PD might also result from different profiles of risk factors, environmental 24 and/or genetic. 26 An alternative explanation may be that most studies rely on a "hospital-clinical population," meaning that there may already be a selection bias at the point of patient recruitment, and even though women tend to be more prone to participate in research 40 in many countries, men may have better access to health care. 41 When using "door-to-door survey" methodology, the figures seem to show either no gender difference in prevalence, 42, 43 or sometimes even higher prevalence of PD in women 44 Furthermore, data concerning an earlier PD onset in men compared to women are not conclusive and need further clarification.
| Gender differences in motor symptoms, disease progression, and complications of dopaminergic therapy in PD patients
As the motor symptoms still form the basis for PD diagnosis, it is interesting to evaluate gender differences in presentation of motor symptoms (Tables 1 and 2 74 (40) 108 ( 155 (51) 152 (49) To compare gender differences in DAT activity using 18F-FP-CIT in healthy subjects
Women showed greater DAT activity in the striatum; age-related DAT decline was greater in the striatum in women 
T A B L E 1 (Continued)
onset of motor symptoms 11 and they are also more likely to present with tremor-dominant PD. 20, 45 Tremor-dominant PD is known to be associated with a slower and more benign disease progression, 1 although the overall motor scores may not necessarily show gender differences. 20 Women also show higher striatal dopaminergic activity 20, 46, 47 , and healthy women even show higher dopaminergic synthetic capacity compared to age-matched healthy men. 48 Other motor symptoms such as writing difficulties and clumsiness were found to be less frequent in women than in men with PD. 23 On the other hand, Augustine et al. 21 did not find differences in motor symptoms and neither in time spent with dyskinesias nor in time spent "off" medication, or in occurrence of early morning dystonia. Similarly, Baba et al. 22 did not find gender differences in the distribution of tremor and bradykinesia in the initial phase of PD, although a higher proportion of women showed a Hoehn and Yahr (H&Y) score above three suggesting more advanced disease at inclusion in women. Furthermore, even though there was no gender difference in the overall motor scores of the Unified Parkinson's Disease rating Scale (UPDRS), women had worse scores in postural instability and had lower rigidity scores, 13, 45, 49 while the rate of disease progression was similar in both sexes. 22 Greater overall severity of motor symptoms in men and worse dyskinesias in women, despite lower L-dopa equivalence daily dose (LEDD) 13, 22, [49] [50] [51] (see Umeh et al. 52 for alternative findings), have also been shown in other studies. 49, 53 In addition, dyskinesias in women occurred earlier after disease onset than in men. 54 Other drug-related motor phenomena are also reported to be more frequent in women. For example, Colombo et al. 55 found a higher prevalence of wearing-offs (WOFs) in women, which together with higher rate T A B L E 2 Gender-specific distribution of motor, non-motor symptoms, and other disease features most frequently reported in studies in PD patients of dyskinesias and shorter latency to develop dyskinesias might be explained by greater L-dopa bioavailability 56 and better response to L-dopa in women. 53 Similar findings were reported in other studies. 57, 58 However, despite higher L-dopa bioavailability in women with PD, Kompoliti et al. 57 did not find gender differences in bioavailability of pramipexole and found no difference in clinical improvement after L-dopa administration. No gender differences in motor symptoms but higher proportion of non-motor fluctuations in women with PD were recently reported by Picillo et al. 59 In conclusion, it seems that women with PD may have more favorable disease profile as motor symptoms emerge later, tremor is more common as first presenting symptom 20 and women with PD tend to be less rigid 22 Some data, however, suggest that women are more prone to develop postural instability than men. 22 Even though treatment with dopamine agonists (DA) does not differ between men and women, 52 it seems that L-dopa-related motor complications, such as dyskinesias and WOFs, are more common in women with PD. 
| Gender differences in NMS, and other disease characteristics in PD patients
In addition to the motor symptoms and signs, NMS and signs form an integral part of the disease manifestations. 60 Possible gender differences in NMS in patients 61, 62 with PD could substantially improve the gender-specific approach in diagnosis and treatment. In addition, NMS do indeed affect patients' ADL and QoL.
| Gender differences in cognition
According to Augustine et al. 21 men show worse cognitive abilities as measured by the overall scores on the Symbol Digit Modalities and the Scale for Outcome of Parkinson Disease Cognition. Worse general cognitive abilities in men with PD have been reported in other studies as well 49, 63 It seems that there is also domain-specific gender difference patterns in cognition, such that men with PD show worse performance on verbal memory tests but better visuospatial abilities. 63, 64 Similar pattern (ie, faster psychomotor speed and higher verbal memory and learning in women, but better visuospatial abilities in men) has been reported in healthy elderly subjects, 63, 65 in patients with mild cognitive impairments without PD 66, 67 
and in patients with
Alzheimer's disease, 67 although some may dispute the validity of these test results in female healthy population (eg, that tests of spatial abilities are not gender neutral 68 ). Contrary to these findings, Gao et al. 53 found lower scores on a number of cognitive tests in women with PD:
In addition to the cognitive domains "traditionally" being reported to be better in men (visuospatial or mathematical abilities), men with PD performed better than women on vocabulary tasks as well. However, in this study men had a higher level of education than women with PD. Furthermore, Foltynie et al. Interestingly, Caranci et al. 70 found association between lower plasma levels of alpha-synuclein and cognitive impairment, hallucinations, psychosis, and apathy in men with advanced-stage PD, but not in women.
| Gender differences in depression, anxiety, apathy, fatigue, and pain
Baba et al. 22 reported a significantly higher proportion of depression in women with PD. Similar findings have been reported in other studies 13, 23, 45, 53, [71] [72] [73] [74] , even though this has not been always replicated. 75 As a matter of caution, it is well known that in general, women are more prone to develop depression. 76, 77 Interestingly in a 2-year follow-up study, Picillo et al. 2014 50 found significant reduction in depression in PD in both sexes;
however, the data were not compared to healthy subjects. Higher anxiety level, 45, 53, 63, 72, 74 higher prevalence of fatigue 45, 71 , and higher proportion of NMS fluctuations (despite no difference in LEDD) 59 in women with PD has also been consistently reported. Meyer et al. 78 found that older age correlated positively with apathy in men, but negatively in women, suggesting a reduced risk of apathy in older women. It also seems that PD-related pain symptoms are more prevalent in women 13, 23, 71 , which again might not be disease specific as this can be seen also in the general population.
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| Gender differences in sleep/REM sleep behavior disorders (RBD)
Bjørnara et al. 81 explored the gender differences with regards to RBD.
Although the prevalence of RBD was higher in men, the difference was not significant. A higher prevalence of RBD in men with PD has been reported in other studies as well, 49 with men showing more fights, violent behavior, and waking by own movements. Male preponderance has also been noted in idiopathic RBD. 82 Other studies have, however, reported higher rate in night-time sleep disturbances in women with PD. 
| Gender differences in autonomic dysfunction and hyposmia
It seems that sexual dysfunction is more prevalent in men with PD. 13, 45, 49, 72, 74 Urinary symptoms have been reported to be more frequent in men, 50, 71 which holds true also for hyposmia. 63, 74 On the other hand, orthostatic hypotension, cardiovascular problems 13 , and weight loss 83 have been found to be more common in women with PD, although these results (eg, orthostatic hypotension) are not unequivocal. 
| Gender differences in impulse control disorders
Compulsive sexual behavior, a part of the impulse control disorders (ICD) spectrum, is known to be more frequent in (younger) men with PD. 84 In addition to low dopamine agonist dose, female gender was found to be a good prognostic factor for ICD resolution. 85 Unlike men, women with PD are more prone to develop impulsive shopping and binge eating. 84 Indeed, main risk factors for the development of ICD in PD are male sex, young age at the time of PD diagnosis, a premorbid history of drug or alcohol abuse, depression, and elevated scores on the personality measure of novelty seeking. 86 This might be important, as avoidance of higher doses of dopaminergic agonists in young male patients might be important to decrease the incidence of ICD in PD.
| Gender differences in activities of daily living (ADL) and quality of life (QoL)
Lubomski et al. 87 evaluated the gender differences in QoL related to motor symptoms in PD. In this study, men reported a greater disease burden than women as noted by higher UPDRS-III scores, higher LEDD, and higher reliance on caregivers. The Parkinson's Disease
Questionnaire (PDQ-39) showed men having lower QoL in the ADL, cognition, and communication domains. On the other hand, Baba et al. 22 found worse ADLs in women with PD; however, improvement of ADL in women after deep brain stimulation (DBS) has been shown to be greater than in men with PD. 88, 89 Lower QoL in women with PD has been reported in other studies as well. 13, 90 In conclusion, there is strong evidence that NMS profiles differ between men and women with PD. One of the most consistent gender differences in the NMS in PD is in the cognitive abilities; it seems that women with PD show better global cognitive abilities than men. 63 While women with PD usually perform better on verbal memory and learning tests, men have better visuospatial abilities. 63 However, it is important to note again that similar pattern of gender-specific differences in cognitive abilities has been described not only in patients with other neurological disorders. 66, 67 but also in healthy subjects. 63, 65 Similarly, higher level of depression and anxiety in women is not PD-specific 50, 63, 74 as it is also seen in the general population. 76, 77 In addition, higher prevalence of chronic pain states and greater pain sensitivity among women in the general population has also been repeatedly reported. 79, 80 Sexual dysfunction and urinary difficulties are more common in men with PD. In general, while some studies show worse QoL and ADL in men with PD, [87] [88] [89] others show the opposite. 
| Gender differences in PD patients treated with stereotactic surgery
There are only few studies reporting gender differences in patients treated with stereotactic surgery. In a meta-analysis, Hariz et al. 91 (see also Hariz et al. 89 Kenny et al. 92 and Chiou et al. were men. Hence, the number of men with PD treated with stereotactic surgery in this meta-analysis exceeded the "usual" male/female predominance in PD. 10 In an earlier study, Hariz et al. 89 explored the gender differences in QoL measures in patients with PD before and after stereotactic treatment for PD. Before surgery, women had a longer disease course, higher stage of disease on the H&Y scale, higher scores of UPDRS-II (ADL) and IV (complications of therapy), and worse scores on the ADL taxonomy and on Schwab and England ADL scale.
Even though motor improvement was similar in both sexes (see also Hariz et al. 89 Accolla et al. 51 and Chiou et al. 93 for gender-related equal motor improvement), 11 months after surgery women showed significantly better improvement in ADL, emotions, and social life. This was replicated in later studies from the same 88 and other groups. 51 In addition, while lower LEDD, higher motor dysfunction (particularly tremor), and greater improvement in tremor and rigidity on L-dopa challenge test were found to predict better operative outcome in men with PD 93 , better ADL scores, despite higher preoperative motor scores, predicted better operative outcome in women with PD. 93 In summary, the evidence from the studies on gender differences in PD patients treated with stereotactic surgery suggests that men are more likely than women to access surgical treatment, 88 which may be related to a gendered referral bias for surgery favoring men, 91 or due to women declining surgery. 94 Interestingly, despite the same motor improvement across sexes, 88 QoL measures and ADL improve more in women than in men, although women have longer disease duration before surgery than men.
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| CONCLUSIONS AND DIRECTIONS FOR FUTURE RESEARCH
The aim of this paper was to review clinical studies exploring the gender differences in PD. The data from the studies reviewed here indicate that there are many potential markers for gender differences in PD. Candidate markers sensitive to gender differences in PD can be found not only among epidemiological characteristics and the motor symptoms, but also among NMS of the disease. In addition, data also suggest differences in QoL and ADL measures of PD (Table 2) .
Summarizing, one of the best established disease characteristics that shows a gender-specific effect is the slightly higher incidence and prevalence of PD among male subjects. 10 In addition, it seems that PD starts earlier in men compared to women possibly due to the protective effect that estrogen has in premenopausal women. 20, 38, 39 Women more often show tremor-dominant PD at disease onset compared to men. 20 It also seems that women are less rigid 22 but display more postural instability than men. 22, 45 Even though the therapy scheme and LEDD seem to be similar in men and women with PD 52 (or sometimes reported to be even higher in men, 22 probably due to better bioavailability of L-dopa in women than men), women are more prone to develop dyskinesias than men. 22, 45 Therefore, a lower LEDD might be recommended in women with PD as part of the gender-specific treatment strategies in PD. The fact that women with PD have more dyskinesias, which usually improve well after DBS, might also be the reason why the QoL improves better in women with PD operated with DBS even though the improvement of bradykinesia, tremor, and rigidity seems to be similar in both genders. 51, 88, 89 Regarding NMS in PD, while in general women show better results on measures of general cognitive abilities as well as on verbal memory and executive tasks, 63 men show better visuospatial cognitive abilities. 63 On the other hand, women with PD show higher level of depression and anxiety. 22 These findings should, however, be interpreted with caution, as a similar gender-specific pattern concerning these non-motor domains has been reported in the healthy population, 63, 65, 76, 77, 79, 80 as well as in patients with other neurological conditions. 66, 67 Regarding the possible gender-specific treatment strategies in PD, as men and women have different needs based on different activates of daily living, different rehabilitation plans can be fit to men and women with PD.
There are few important issues that have to be taken into consideration when planning future research on gender differences in PD: controlled, prospective, longitudinal studies specifically looking at the issue of gender differences in clinical presentation of PD (see Picillo et al. 50 a short-term follow-up study on gender differences in PD) are lacking.
Possible changes over time might be expected not only quantitatively (ie, severity of symptoms), but also in the quality/gender-related pattern of symptoms and signs. This can also trigger potential research on the basic mechanisms that underlie these changes. 96 Furthermore, it is important to compare results in PD with matched healthy subjects, as many characteristics that account for the gender differences seen in general population are also reflected in PD. 63 Therefore, future studies on the gender differences in PD (and other neurological disorders)
should always include comparison with matched healthy controls, as this may have important implications for the interpretation of gender differences in PD and other neurological conditions.
Aside from this review, good-quality basic studies specifically exploring the issue of gender differences in PD at different levels-molecular, cellular, network, and system levels-are needed. For example,
there are only few studies on gender differences in the electrophysiological characteristics of the disease. 97 There is also lack of studies directly correlating possible basic mechanisms and clinically observable gender differences in PD (translational research). Therefore, goodquality (basic and clinical) studies on gender differences in PD may lead to identification of reliable gender-sensitive markers that can be used to approach patients in a gender-specific manner-from diagnosis, through treatment to addressing socioeconomic issues related to PD. Indeed, there is a continuous need for research about gender bias in medical investigations and treatments in everyday clinical practice in general 98 with a final aim to better improve the quality of life and well-being of all patients, irrespective of gender.
